Evidence map›Paper›PMID 31242269›Full record

ArticlePloS one2019

Isolation, culturing and gene expression profiling of inner mass cells from stable and vulnerable carotid atherosclerotic plaques.

Olga A Novikova, Zhanna K Nazarkina, Anna V Cherepanova, Petr P Laktionov, Boris P Chelobanov, Ivan S Murashov, Roman V Deev, Evgeny A Pokushalov, Andrey A Karpenko, Pavel P Laktionov

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Human Plaque Myofibroblasts to Study Mechanisms of Atherosclerosis.Journal of the American Heart Association · 2023
    Article
  3. Article
  4. The Mechanisms of the Development of Atherosclerosis in Prediabetes.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Olga A Novikova"E. Meshalkin National Medical Research Center", Ministry of Health of the Russian Federation, Novosibirsk, Russia.
Zhanna K NazarkinaLaboratory of Molecular Medicine, SB RAS Institute of Chemical Biology and Fundamental Medicine, Novosibirsk, Russia.
Anna V Cherepanova"E. Meshalkin National Medical Research Center", Ministry of Health of the Russian Federation, Novosibirsk, Russia.ORCID 0000-0003-3083-7541
Petr P LaktionovLaboratory of Genomics, SB RAS Institute of Molecular and Cellular Biology, Novosibirsk, Russia.
Boris P ChelobanovLaboratory of Molecular Medicine, SB RAS Institute of Chemical Biology and Fundamental Medicine, Novosibirsk, Russia.
Ivan S Murashov"E. Meshalkin National Medical Research Center", Ministry of Health of the Russian Federation, Novosibirsk, Russia.
Roman V DeevRyazan State Medical University, Ryazan, Russia.
Evgeny A Pokushalov"E. Meshalkin National Medical Research Center", Ministry of Health of the Russian Federation, Novosibirsk, Russia.
Andrey A Karpenko"E. Meshalkin National Medical Research Center", Ministry of Health of the Russian Federation, Novosibirsk, Russia.
Pavel P Laktionov"E. Meshalkin National Medical Research Center", Ministry of Health of the Russian Federation, Novosibirsk, Russia.
Institute of Chemical Biology and Fundamental Medicine · RUMinistry of Health of the Russian Federation · RUNovosibirsk State University · RURyazan State Medical University named after Academician I.P. Pavlov · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The connective tissue components that form the atherosclerotic plaque body are produced by the plaque inner mass cells (PIMC), located inside the plaque. We report an approach to isolate and culture cells from the connective tissue of stable and vulnerable human atherosclerotic plaques based on elimination of non-connective tissue cells such as blood and non-plaque intima cells with a lysis buffer. The resulting plaque cells were characterized by growth capacity, morphology, transcriptome profiling and specific protein expression. Plaque cells slowly proliferated for up to three passages unaffected by the use of proliferation stimulants or changes of culture media composition. Stable plaques yielded more cells than vulnerable ones. Plaque cell cultures also contained several morphological cellular types. RNA-seq profiles of plaque cells were different from any of the cell types known to be involved in atherogenesis. The expression of the following proteins was observed in cultured plaque cells: smooth muscle cells marker α-SMA, macrophage marker CD14, extracellular matrix proteins aggrecan, fibronectin, neovascularisation markers VEGF-A, CD105, cellular adhesion receptor CD31 and progenitor/dedifferentiation receptor CD34. Differential expression of several notable transcripts in cells from stable and vulnerable plaques suggests the value of plaque cell culture studies for the search of plaque vulnerability markers.

Indexed as

ActinsAgedAntigens, CDAtherosclerosisBiomarkersCarotid ArteriesCell ProliferationFemaleGene Expression ProfilingHumansMacrophagesMaleMyocytes, Smooth MusclePlaque, AtheroscleroticTranscriptomeVascular Endothelial Growth Factor AActinsAntigens, CDBiomarkersVascular Endothelial Growth Factor A

Identifiers

PMID31242269
PMCPMC6594632
OpenAlexW2955344796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.